GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,077,000 | -17.8% | 162,603 | -17.7% | 0.00% | +33.3% |
Q1 2022 | $8,606,000 | -2.5% | 197,459 | -1.4% | 0.00% | 0.0% |
Q4 2021 | $8,829,000 | +43.7% | 200,196 | +24.4% | 0.00% | +50.0% |
Q3 2021 | $6,145,000 | +54.3% | 160,957 | +60.9% | 0.00% | 0.0% |
Q2 2021 | $3,982,000 | +69.4% | 100,034 | +52.0% | 0.00% | +100.0% |
Q1 2021 | $2,351,000 | -4.9% | 65,833 | -2.1% | 0.00% | 0.0% |
Q4 2020 | $2,473,000 | -4.1% | 67,217 | -1.9% | 0.00% | 0.0% |
Q3 2020 | $2,579,000 | +4.6% | 68,517 | +14.2% | 0.00% | 0.0% |
Q2 2020 | $2,465,000 | +70.0% | 60,023 | +56.7% | 0.00% | 0.0% |
Q1 2020 | $1,450,000 | -2.2% | 38,297 | +21.4% | 0.00% | 0.0% |
Q4 2019 | $1,483,000 | +30.0% | 31,550 | +4.4% | 0.00% | 0.0% |
Q3 2019 | $1,141,000 | +56.3% | 30,230 | +65.7% | 0.00% | – |
Q2 2019 | $730,000 | -47.1% | 18,243 | -44.8% | 0.00% | -100.0% |
Q1 2019 | $1,381,000 | +8.0% | 33,050 | -1.3% | 0.00% | 0.0% |
Q4 2018 | $1,279,000 | -6.8% | 33,480 | -2.0% | 0.00% | 0.0% |
Q3 2018 | $1,372,000 | -81.3% | 34,163 | -81.2% | 0.00% | -75.0% |
Q2 2018 | $7,321,000 | +5.8% | 181,628 | +2.5% | 0.00% | 0.0% |
Q1 2018 | $6,921,000 | +13.9% | 177,169 | +3.4% | 0.00% | +33.3% |
Q4 2017 | $6,076,000 | -22.6% | 171,290 | -11.4% | 0.00% | -25.0% |
Q3 2017 | $7,851,000 | -12.4% | 193,348 | -7.0% | 0.00% | 0.0% |
Q2 2017 | $8,966,000 | +1.9% | 207,935 | -0.3% | 0.00% | 0.0% |
Q1 2017 | $8,797,000 | +3.6% | 208,638 | -5.4% | 0.00% | 0.0% |
Q4 2016 | $8,494,000 | -22.3% | 220,570 | -13.0% | 0.00% | -33.3% |
Q3 2016 | $10,926,000 | -6.8% | 253,391 | -6.4% | 0.01% | 0.0% |
Q2 2016 | $11,726,000 | -25.1% | 270,574 | -29.9% | 0.01% | -25.0% |
Q1 2016 | $15,658,000 | +2.2% | 386,150 | +1.7% | 0.01% | 0.0% |
Q4 2015 | $15,319,000 | -0.5% | 379,643 | -5.2% | 0.01% | 0.0% |
Q3 2015 | $15,398,000 | +223.2% | 400,490 | +250.2% | 0.01% | +300.0% |
Q2 2015 | $4,764,000 | -65.8% | 114,371 | -62.1% | 0.00% | -66.7% |
Q1 2015 | $13,928,000 | +9.3% | 301,807 | +1.2% | 0.01% | 0.0% |
Q4 2014 | $12,748,000 | -16.8% | 298,289 | -10.5% | 0.01% | -14.3% |
Q3 2014 | $15,315,000 | -19.5% | 333,132 | -6.3% | 0.01% | -12.5% |
Q2 2014 | $19,023,000 | +0.7% | 355,704 | +0.6% | 0.01% | -11.1% |
Q1 2014 | $18,887,000 | -0.7% | 353,505 | -0.8% | 0.01% | 0.0% |
Q4 2013 | $19,018,000 | +17.8% | 356,203 | +10.6% | 0.01% | 0.0% |
Q3 2013 | $16,151,000 | +14.7% | 321,922 | +14.2% | 0.01% | +12.5% |
Q2 2013 | $14,084,000 | – | 281,858 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |